about
Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia.Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance.The human Tp53 Arg72Pro polymorphism explains different functional prognosis in stroke.Interleukin-10 facilitates the selection of patients for systemic thrombolysis.Hyperthermia in human ischemic and hemorrhagic stroke: similar outcome, different mechanismsAssociation between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke.Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic valuesNeuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental studyHigh blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke.White matter injury restoration after stem cell administration in subcortical ischemic stroke.Neuroplasticity and cellular therapy in cerebral infarction.Increased Endothelial Progenitor Cell Levels are Associated with Good Outcome in Intracerebral Hemorrhage.High serum levels of pro-brain natriuretic peptide (pro BNP) identify cardioembolic origin in undetermined stroke.Inflammatory and neuroimmunomodulatory changes in acute cerebral ischemia.In vivo theranostics at the peri-infarct region in cerebral ischemia.Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia.Neovascularization and functional recovery after intracerebral hemorrhage is conditioned by the Tp53 Arg72Pro single-nucleotide polymorphismTargeting the ischemic penumbra.Oxaloacetate: a novel neuroprotective for acute ischemic stroke.Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: a systematic review and meta-analysis.A novel mechanism of neuroprotection: Blood glutamate grabber.Endothelial progenitor cells as a therapeutic option in intracerebral hemorrhage.Vectorized nanodelivery systems for ischemic stroke: a concept and a need.Positron Emission Tomography for the Development and Characterization of Corneal Permanence of Ophthalmic Pharmaceutical Formulations.Easy and Efficient Cell Tagging with Block Copolymer-Based Contrast Agents for Sensitive MRI Detection in Vivo.Endothelial Progenitor Cells as a Therapeutic Approach for Intracerebral Hemorrhage.Reported Prestroke Physical Activity Is Associated with Vascular Endothelial Growth Factor Expression and Good Outcomes after Stroke.Prestroke physical activity is associated with good functional outcome and arterial recanalization after stroke due to a large vessel occlusion.Hyperthermia is a surrogate marker of inflammation-mediated cause of brain damage in acute ischaemic stroke.Study of Protein Expression in Peri-Infarct Tissue after Cerebral Ischemia.Higher Expression of Toll-Like Receptors 2 and 4 in Blood Cells of Keratoconus Patiens.Neuroprotective effect of neuroserpin in rat primary cortical cultures after oxygen and glucose deprivation and tPA.proMetalloproteinase-10 is associated with brain damage and clinical outcome in acute ischemic stroke.The effect of simvastatin on the proteome of detergent-resistant membrane domains: decreases of specific proteins previously related to cytoskeleton regulation, calcium homeostasis and cell fate.Blood glutamate grabbing does not reduce the hematoma in an intracerebral hemorrhage model but it is a safe excitotoxic treatment modality.Glutamate oxaloacetate transaminase: a new key in the dysregulation of glutamate in migraine patients.High pro-BNP levels predict the occurrence of atrial fibrillation after cryptogenic stroke.Neuronal excitotoxicity after carotid angioplasty and stent placement procedures.Plasma beta-amyloid 1-40 is associated with the diffuse small vessel disease subtype.High serum levels of growth factors are associated with good outcome in intracerebral hemorrhage.
P50
Q30579549-6725A871-20D6-4652-9285-56EAE1DB8653Q33884666-F0F726BA-23F3-4901-9E31-2FFBC4A738C9Q34681421-0F23B710-4C6B-4B62-8A3B-89B8EB436467Q34774865-0401F350-EE1D-4952-A399-3DD28D1C2346Q35040910-C2B69A13-813F-4BB6-8D04-B54DBBE63724Q35042229-B640BA8F-31C9-4232-97D7-5081B8520A78Q35088188-D20FB4F8-C5F3-400C-B2CB-86CF5E1A0775Q35088219-25343235-8503-436F-BE58-42BD3F9447CBQ35088233-C5AC4D8D-22D1-48DF-9664-0E0C50FFB7B5Q35885598-BD055E51-E596-4F37-ABEB-690D519038D7Q36986440-32E2003A-3967-47BF-92F5-C4FD0D798F34Q37039953-404B653A-A8CC-4CD6-86CA-8F73EF3D402EQ37324392-17D3102B-0405-4FFA-A656-7C029B484F7DQ37431238-64A60F25-C2E0-456F-959A-D365BD09B324Q37435231-B8B1536F-8D8B-4C45-9EBC-986BB3CB26A0Q37587747-44310741-79A2-4236-951F-796792698274Q37602864-5A12B35F-6DE0-46AB-B7C2-31A5970856BDQ37821638-190AD88D-2B03-4FC5-B4CE-B3CFC1DAFCB2Q37956426-390AF706-7319-4398-9704-835BB6C3B3B8Q38236852-9199FADD-03EC-45FE-B447-25216B6AB4B8Q38557491-85243F4D-0EAA-471A-A121-BCB9FC444F33Q38677879-8F320E73-2109-4BD5-BA3F-38C45E5814E0Q38731765-E58E21A4-3507-4DA5-98BA-0BEB4E4976D9Q38763340-AF5C1E6A-A20F-472C-8A86-1ED2844446D0Q38777093-1240E5B5-7198-4B8B-839D-743D00EEE659Q38779619-DA340C94-B119-4A3A-92DD-2B98A0716EB8Q39059634-0820537F-B2A8-4BA6-A7AF-50318F4F180FQ39188249-EE122813-51CD-4A66-82EB-2CBB8F8AF165Q40470454-4B452A7E-F7CF-43EA-B576-C7B9AE0676E3Q40759579-76DF4FFE-17EF-4D3A-8E71-28331149A74DQ42374933-7AC53B59-3B68-423B-9394-BB38D57A393DQ42481375-7701157E-E7DF-4980-B315-FCED5BC7C75AQ42710833-837C2AE7-0F05-4B48-8A3B-107707F797E4Q43135884-9C1190F1-488B-4D3E-ABD9-A0732A4B68F6Q43181364-24A6D06B-0103-47F1-9611-1CCB10592096Q43358780-8E66CD58-6564-457F-9BF4-1C688275971FQ44255695-0CF607F4-C932-4E99-BC34-DEE335B6CF4FQ44345672-9BF9B439-B602-4FE9-AAD1-E65E46D43DABQ44367150-4C484C61-C2DE-42D0-AD37-0B9A222CDC8EQ44610130-24E198DC-428C-43D9-B380-8B8F5E65E316
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tomás Sobrino
@ast
Tomás Sobrino
@en
Tomás Sobrino
@es
Tomás Sobrino
@nl
Tomás Sobrino
@sl
type
label
Tomás Sobrino
@ast
Tomás Sobrino
@en
Tomás Sobrino
@es
Tomás Sobrino
@nl
Tomás Sobrino
@sl
prefLabel
Tomás Sobrino
@ast
Tomás Sobrino
@en
Tomás Sobrino
@es
Tomás Sobrino
@nl
Tomás Sobrino
@sl
P1053
D-2498-2017
P106
P1153
12769820300
P21
P31
P3829
P496
0000-0002-9760-8690